CLL

Understanding CLL as a chronic disease.

Knowing treatment options and the possibilities of supportive care.

Utilizing clinical trials and understanding potential side effects and complications.

Finding follow-up care and emotional support.

Serving as a caregiver for a loved one going through a CLL diagnosis and treatment while utilizing resources to take care of oneself.

A list of helpful resources to assist people with CLL and their families cope with the emotional and practical aspects of the disease.

Imbruvica (ibrutinib) may be superior to standard of care in elderly patients with untreated chronic lymphocytic leukemia (CLL), according to phase 3 findings published in the New England Journal of Medicine.

Ian W. Flinn, M.D., Ph.D., discusses the use of Copiktra, which was approved in September for patients with relapsed/refractory chronic lymphocytic leukemia.

The Food and Drug Administration approved Imbruvica plus Gazyva for treatment-naïve patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

Will the word "cure" be used for patients with chronic lymphocytic leukemia (CLL)?

Brian Koffman is a family physician who used his own CLL diagnosis to start a group that informs other patients and their loved ones.

The combination use of Imbruvica (ibrutinib) with Rituxan (rituximab) significantly improved survival outcomes compared with standard of care in younger patients with chronic lymphocytic leukemia (CLL).

Former NFL coach discusses how cancer motivated him to appreciate life.